カテゴリ： GlobalData, ドイツ, 企業調査

Merck KGaA (MRK)：医療機器：M&Aディール及び事業提携情報

◆英語タイトル：Merck KGaA (MRK) - Medical Equipment - Deals and Alliances Profile
◆商品コード：DATA904C7292
◆発行会社（調査会社）：GlobalData
◆発行日：2018年10月
◆ページ数：123
◆レポート言語：英語
◆レポート形式：PDF
◆納品方法：Eメール
◆対象地域：ドイツ
◆産業分野：医療機器
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD250 ⇒換算￥37,000見積依頼/購入/質問フォーム
Site License（同一事業所内共有可）USD500 ⇒換算￥74,000見積依頼/購入/質問フォーム
Enterprisewide License（複数事業所内共有可）USD750 ⇒換算￥111,000見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※GlobalData社の概要はこちらでご確認いただけます。

このエントリーをはてなブックマークに追加
LINEで送る


【レポートの概要】

Summary
Merck KGaA (Merck), a subsidiary of E. Merck KG, is a pharmaceutical and chemical company. It discovers, develops and manufactures prescription drugs to treat cancer, multiple sclerosis, and infertility and over-the-counter products for colds and pain; and develops liquid crystal mixtures, OLED materials and cosmetic active ingredients. The company also provides a wide range of products including lab water systems to gene editing tools, cell lines, antibodies and end-to-end systems. Merck serves healthcare, performance materials and life sciences markets. It has presence in Europe, North America, Asia-Pacific, Latin America and Middle East and Africa. Merck is headquartered in Darmstadt, Hesse, Germany.

Merck KGaA (MRK) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 6
List of Figures 7
Merck KGaA, Medical Equipment, Deals By Year, 2012 to YTD 2018 8
Merck KGaA, Medical Equipment Deals By Type, 2012 to YTD 2018 9
Merck KGaA, Medical Equipment, Deals By Region, 2012 to YTD 2018 10
Merck KGaA, Medical Equipment, Deals By Market, 2012 to YTD 2018 11
Merck KGaA, Medical Equipment, Deals Summary, 2012 to YTD 2018 12
Merck KGaA, Medical Equipment, Deal Details 15
Asset Purchase 15
Sigma-Aldrich Acquires Duolink Product Portfolio from Olink Bioscience 15
BioReliance To Acquire Rights To Big Blue Colonies and Cell Lines From Agilent Technologies 16
Venture Financing 17
DNA Script Raises USD13.2 Million in Series A Financing 17
SerImmune Raises USD8 Million in Venture Financing 19
Partnerships 20
Sysmex Enters Into Licensing Agreement With Merck Millipore 20
MDxHealth Enters Into Licensing Agreement With Merck For MGMT Diagnostic Test 21
Merck and ArcherDX Enter into Co-Development Agreement 22
Definiens Enters into Co-Development Agreement with Merck 23
Merck Enters into Co-Development Agreement with Alibaba Health 24
MilliporeSigma Enters into Distribution Agreement with HistoCyte Labs 25
Foundation Medicine Enters into Partnership with Merck 26
HTG Molecular Diagnostics Enters into Agreement with Merck 27
Exosome Diagnostics Enters into Agreement with Merck 28
Guardant Health Enters into Agreement with AstraZeneca, Merck and Pfizer 29
BioMed X Enters into Agreement with Merck 30
HTG Molecular Diagnostics Enters into Agreement with Merck 31
R-Biopharm Enters into Agreement with Merck 32
Emulate Expands Research Agreement with Merck 33
Merck and Pfizer Enters into Agreement with Dako 34
Sigma-Aldrich Enters into Distribution Agreement with LGC 35
Sigma-Aldrich and GenapSys to Co-Market Genius system 36
Merck Serono Enters into Co- Development Agreement with Illumina 37
Abcam Enters into Co-Marketing Agreement with Cell Marque for IVD IHC RabMAb Antibodies 38
Ventana Medical Systems Enters into Co-Development Agreement with Merck Serono for Companion Diagnostic Test 39
True Diagnostics Enters into Co-Marketing Agreement With Merck 40
Sigma-Aldrich Enters Into Distribution Agreement With Biomatrica For Biospecimen Storage Products 41
Firefly BioWorks Enters Into Distribution Agreement With EMD Millipore 42
Life Technologies Enters Into Agreement With Merck Serono To Develop And Commercialize Companion Diagnostics 43
Gyros And EMD Millipore Enter Into Agreement To Develop And Commercialize Immunoassay Kits 44
Luminex Extends Distribution Agreement With EMD Millipore 45
Alchemia Enters Into Collaboration Agreement with Merck Serono 46
GE Healthcare Life Sciences Enters Into Distribution Agreement With Sigma-Aldrich 47
Sigma Life Science Enters Into Distribution Agreement With Olink Bioscience For Duolink Technology 48
EMD Millipore Enters Into Co-Development Agreement With Sistemic For Stem Cell Markers 49
Merck Serono Enters Into Co-Development Agreement With Auxogyn For Early Embryo Viability Assessment Test 50
Sage Labs Enters Into Agreement With Ekam Imaging To Develop Imaging Assays 51
SciFluor Life Sciences Enters Into Distribution Agreement With Sigma-Aldrich For PhenoFluor 52
Little Things Factory Enters Into Distribution Agreement With Sigma-Aldrich For Microreactors 53
Mendor Enters Into Distribution Agreement With Merck Serono 54
EMD Millipore Enters into Licensing Agreement with Singulex 55
Merck Extends Licensing Agreement with Progyny 56
Sigma-Aldrich Enters Into Licensing Agreement With Scripps Research Institute For Research Reagents 57
Cyprotex Enters Into Licensing Agreement With Sigma For Zinc Finger Nuclease Technology 58
Equity Offering 59
KalVista Pharma Raises USD9.1 Million in Private Placement of Shares 59
Debt Offering 60
Merck Raises USD916 Million in Private Placement of 0.75% Bonds Due 2019 60
Merck Raises USD801.4 Million in Private Placement of 0.23% Bonds Due 2017 61
Merck Raises USD629.7 Million in Private Placement of 1.375% Bonds Due 2022 62
Asset Transactions 63
Zydus Healthcare Acquires Six Brands from Merck 63
Honeywell International Acquires Research Chemicals Business from Sigma-Aldrich 64
Acquisition 66
Merck to Acquire Natrix Separations 66
Merck Acquires Sigma-Aldrich for USD17 Billion 67
Sigma-Aldrich Acquires Cell Marque 69
Proxy Labs Acquires MicroSafe Laboratories From Millipore 70
Merck KGaA – Key Competitors 71
Merck KGaA – Key Employees 72
Merck KGaA – Locations And Subsidiaries 73
Head Office 73
Other Locations & Subsidiaries 73
Recent Developments 83
Strategy And Business Planning 83
Sep 28, 2017: Merck On Course To Achieve Objectives for 2018 83
Sep 05, 2017: Merck Prepares Strategic Options for the Consumer Health Business 85
Jul 21, 2017: Merck Opens New Application Laboratory in Shanghai 86
Jun 29, 2017: Merck Expands Packaging Capacity at Swiss Biotech Manufacturing Site of Aubonne 87
Jun 20, 2017: Merck Ventures Creates New Immuno-Oncology Company iOnctura 88
May 16, 2017: Merck: Optimizing the Further Development of the Darmstadt Site 89
Apr 20, 2017: Merck Provides Upgraded Manufacturing Capabilities to BioInvent with Single-use Mobius Bioreactors 90
Jan 17, 2017: Merck Opens Production Facility Exclusively for Meglumine in Spain 91
Financial Announcements 92
Feb 02, 2018: Merck Announces Fourth-Quarter and Full-Year 2017 Financial Results 92
Nov 09, 2017: Merck Confirms Outlook for 2017 Despite a Challenging Third Quarter 97
Aug 03, 2017: Q2 2017: Merck Sets Course for Future Growth 99
May 18, 2017: Merck Continues to Grow Profitably in the First Quarter 101
Corporate Communications 103
Jan 26, 2018: Merck Appoints Dirk Toepfer as Chief Information Officer 103
Dec 15, 2017: Petra Wicklandt Appointed Head of Corporate Affairs at Merck 104
Dec 12, 2017: Allan Gabor Takes Over the Leadership of Merck in China 105
Dec 06, 2017: Merck: Resignation of Managing Director 106
Sep 11, 2017: Merck Names Heidi Fagerholm as New Head of Advanced Technologies 107
Aug 03, 2017: Executive Board Changes at Merck 108
Jul 21, 2017: Merck Opens New Application Laboratory in Shanghai 109
May 12, 2017: Constantin Birnstiel to Become Head of Group Communications at Merck 110
Feb 08, 2017: North American Businesses of Merck Certified as 2017 Top Employer 111
Product News 112
Apr 04, 2018: MilliporeSigma to Launch New Flow Cytometer, Host CellStream Workshop at CYTO 2018 112
Other Significant Developments 113
Jul 26, 2018: Merck and Innocore pharmaceuticals to improve patient compliance with new drug delivery technology 113
Jun 19, 2018: Merck to distribute HistoCyte Laboratories’ cell line products 114
Apr 05, 2018: Merck and Schneider Electric Sign MoU to Advance China’s Biopharmaceutical Industry 115
Feb 21, 2018: Merck Invests Additional €40 Million to Enhance Manufacturing and Distribution in Asia 116
Jul 12, 2017: Merck Refines Western European Life Science Production Site Network 117
May 18, 2017: Rational Surgical Solutions integrates Merck Manual of Medicine into Surgery CareSite 118
Mar 21, 2017: Merck Accelerator Hits New Peak of Applications 119
Mar 09, 2017: Merck Generates Record Sales and Continues to Grow Profitably in 2016 120
Jan 12, 2017: Merck and Palantir Launch New Healthcare Acceleration Partnership 122
Appendix 123
Methodology 123
About GlobalData 123
Contact Us 123
Disclaimer 123

List of Tables
Merck KGaA, Medical Equipment, Key Facts, 2017 2
Merck KGaA, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Merck KGaA, Medical Equipment, Deals By Year, 2012 to YTD 2018 8
Merck KGaA, Medical Equipment Deals By Type, 2012 to YTD 2018 9
Merck KGaA, Medical Equipment, Deals By Region, 2012 to YTD 2018 10
Merck KGaA, Deals By Market, 2012 to YTD 2018 11
Merck KGaA, Medical Equipment, Deals Summary, 2012 to YTD 2018 12
Sigma-Aldrich Acquires Duolink Product Portfolio from Olink Bioscience 15
BioReliance To Acquire Rights To Big Blue Colonies and Cell Lines From Agilent Technologies 16
DNA Script Raises USD13.2 Million in Series A Financing 17
SerImmune Raises USD8 Million in Venture Financing 19
Sysmex Enters Into Licensing Agreement With Merck Millipore 20
MDxHealth Enters Into Licensing Agreement With Merck For MGMT Diagnostic Test 21
Merck and ArcherDX Enter into Co-Development Agreement 22
Definiens Enters into Co-Development Agreement with Merck 23
Merck Enters into Co-Development Agreement with Alibaba Health 24
MilliporeSigma Enters into Distribution Agreement with HistoCyte Labs 25
Foundation Medicine Enters into Partnership with Merck 26
HTG Molecular Diagnostics Enters into Agreement with Merck 27
Exosome Diagnostics Enters into Agreement with Merck 28
Guardant Health Enters into Agreement with AstraZeneca, Merck and Pfizer 29
BioMed X Enters into Agreement with Merck 30
HTG Molecular Diagnostics Enters into Agreement with Merck 31
R-Biopharm Enters into Agreement with Merck 32
Emulate Expands Research Agreement with Merck 33
Merck and Pfizer Enters into Agreement with Dako 34
Sigma-Aldrich Enters into Distribution Agreement with LGC 35
Sigma-Aldrich and GenapSys to Co-Market Genius system 36
Merck Serono Enters into Co- Development Agreement with Illumina 37
Abcam Enters into Co-Marketing Agreement with Cell Marque for IVD IHC RabMAb Antibodies 38
Ventana Medical Systems Enters into Co-Development Agreement with Merck Serono for Companion Diagnostic Test 39
True Diagnostics Enters into Co-Marketing Agreement With Merck 40
Sigma-Aldrich Enters Into Distribution Agreement With Biomatrica For Biospecimen Storage Products 41
Firefly BioWorks Enters Into Distribution Agreement With EMD Millipore 42
Life Technologies Enters Into Agreement With Merck Serono To Develop And Commercialize Companion Diagnostics 43
Gyros And EMD Millipore Enter Into Agreement To Develop And Commercialize Immunoassay Kits 44
Luminex Extends Distribution Agreement With EMD Millipore 45
Alchemia Enters Into Collaboration Agreement with Merck Serono 46
GE Healthcare Life Sciences Enters Into Distribution Agreement With Sigma-Aldrich 47
Sigma Life Science Enters Into Distribution Agreement With Olink Bioscience For Duolink Technology 48
EMD Millipore Enters Into Co-Development Agreement With Sistemic For Stem Cell Markers 49
Merck Serono Enters Into Co-Development Agreement With Auxogyn For Early Embryo Viability Assessment Test 50
Sage Labs Enters Into Agreement With Ekam Imaging To Develop Imaging Assays 51
SciFluor Life Sciences Enters Into Distribution Agreement With Sigma-Aldrich For PhenoFluor 52
Little Things Factory Enters Into Distribution Agreement With Sigma-Aldrich For Microreactors 53
Mendor Enters Into Distribution Agreement With Merck Serono 54
EMD Millipore Enters into Licensing Agreement with Singulex 55
Merck Extends Licensing Agreement with Progyny 56
Sigma-Aldrich Enters Into Licensing Agreement With Scripps Research Institute For Research Reagents 57
Cyprotex Enters Into Licensing Agreement With Sigma For Zinc Finger Nuclease Technology 58
KalVista Pharma Raises USD9.1 Million in Private Placement of Shares 59
Merck Raises USD916 Million in Private Placement of 0.75% Bonds Due 2019 60
Merck Raises USD801.4 Million in Private Placement of 0.23% Bonds Due 2017 61
Merck Raises USD629.7 Million in Private Placement of 1.375% Bonds Due 2022 62
Zydus Healthcare Acquires Six Brands from Merck 63
Honeywell International Acquires Research Chemicals Business from Sigma-Aldrich 64
Merck to Acquire Natrix Separations 66
Merck Acquires Sigma-Aldrich for USD17 Billion 67
Sigma-Aldrich Acquires Cell Marque 69
Proxy Labs Acquires MicroSafe Laboratories From Millipore 70
Merck KGaA, Key Competitors 71
Merck KGaA, Key Employees 72
Merck KGaA, Subsidiaries 73

List of Figures
Merck KGaA, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Merck KGaA, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Merck KGaA, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Merck KGaA, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Merck KGaA, Medical Equipment, Deals By Year, 2012 to YTD 2018 8
Merck KGaA, Medical Equipment, Deals by Type, 2012 to YTD 2018 9
Merck KGaA, Medical Equipment, Deals By Region, 2012 to YTD 2018 10
Merck KGaA, Medical Equipment, Deals by Market, 2012 to YTD 2018 11

★海外企業調査レポート[Merck KGaA (MRK)：医療機器：M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら
■おすすめ企業レポート■
  • Genae Associates NV：医療機器：M&Aディール及び事業提携情報
    Summary Genae Associates NV (Genae Group) is a medical device CRO that offers clinical trial management services. The organization develops and commercializes investigational products and therapies that advance practices in medicine. Its services comprise clinical trial management, regulatory and sa …
  • CJ ENM Co Ltd (035760)：企業の財務・戦略的SWOT分析
    CJ ENM Co Ltd (035760) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Hibu Group Limited：戦略・SWOT・企業財務分析
    Hibu Group Limited - Strategy, SWOT and Corporate Finance Report Summary Hibu Group Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Active Biotech AB (ACTI)：製薬・医療：M&Aディール及び事業提携情報
    Summary Active Biotech AB (Active Biotech) is a biotechnology company that develops and commercializes pharmaceuticals in the field of inflammatory/neurodegenerative diseases and cancer. The company’s key products in development include Laquinimod (neurodegenerative diseases); Anyara (cancer); Tasqu …
  • Holland America Line Inc：企業の戦略的SWOT分析
    Holland America Line Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • Tampa Electric Co：電力：M&Aディール及び事業提携情報
    Summary Tampa Electric Company (TEC), a subsidiary of Emera Inc., is an energy utility. It conducts the generation, purchase, transmission, distribution and sale of electricity and the distribution, purchase and sale of natural gas in Florida. The service area for electric operations covers West Cen …
  • AccorHotels：戦略・SWOT・企業財務分析
    AccorHotels - Strategy, SWOT and Corporate Finance Report Summary AccorHotels - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Bridgestone Corporation：企業の戦略・SWOT・財務情報
    Bridgestone Corporation - Strategy, SWOT and Corporate Finance Report Summary Bridgestone Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Efore Oyj (EFO1V)：企業の財務・戦略的SWOT分析
    Efore Oyj (EFO1V) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • NIKE Inc：企業のM&A・事業提携・投資動向
    NIKE Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's NIKE Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital …
  • BioLamina AB：製薬・医療：M&Aディール及び事業提携情報
    Summary BioLamina AB (BioLamina) is a biotechnology company that focuses on the development, manufacture and distribution of cell culture reagents intended for culturing primary cells. The company offers a wide portfolio of chemically defined and xeno-free laminin proteins. Its product portfolio inc …
  • Max India Ltd：企業のM&A・事業提携・投資動向
    Max India Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Max India Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments …
  • Student Transportation Inc.
    Student Transportation Inc. - Strategy, SWOT and Corporate Finance Report Summary Student Transportation Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • World Fuel Services Corporation：企業のM&A・事業提携・投資動向
    World Fuel Services Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's World Fuel Services Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers …
  • Gliknik Inc：製薬・医療：M&Aディール及び事業提携情報
    Summary Gliknik Inc (Gliknik) is a biopharmaceutical company that develops therapies for patients suffering from cancer and immune disorders. The company’s pipeline products include biropepimut-S (GL-0817) and GL-2045. Its biropepimut-S is an engineered peptide immunomodulator targeted against impor …
  • Aurora Health Care Inc：企業の戦略的SWOT分析
    Aurora Health Care Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Fresenius Kidney Care-製薬・医療分野：企業M&A・提携分析
    Summary Fresenius Kidney Care (FMCNA) , formerly Fresenius Medical Care Holdings Inc, a subsidiary of Fresenius Medical Care AG & Co KGaA, is a provider of dialysis services and renal care products. The company’s dialysis products include hemodialysis; dialyzers, haemodialysis machines, FMiS medical …
  • Gemini Corp (GKX)-石油・ガス分野：企業M&A・提携分析
    Summary Gemini Corporation (Gemini) is an oil and gas engineering company that provides engineering, field and environmental solutions. The company offers services including project management systems, fabrication, maintenance, procurement, construction, land, environmental, regulatory, and reclamat …
  • ALS Ltd (ALQ)：企業の財務・戦略的SWOT分析
    ALS Ltd (ALQ) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the pot …
  • Downer EDI Ltd (DOW)-エネルギー分野：企業M&A・提携分析
    Summary Downer EDI Limited (Downer) is a diversified services company. The company offers wide range of services such as transport infrastructure, engineering, utility, construction, and maintenance., It also provides mining services such as open-cut mining, crushing, underground mining operations, …

◆H&Iグローバルリサーチ株式会社のお客様（例）◆